Factors Influencing Effectiveness of Deferiprone in a Thalassaemia major Clinical Setting

Publisher： Karger

E-ISSN： 1421-9662|104|2-3|99-102

ISSN： 0001-5792

Source： Acta Haematologica, Vol.104, Iss.2-3, 2001-01, pp. : 99-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Deferiprone on Immune Status and Cytokine Pattern in Thalassaemia major

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 144-149

Karger

Access to resources Recommend Favorite

Five-Year Trial of Deferiprone Chelation Therapy in Thalassaemia major Patients

By  

Acta Haematologica, Vol. 112, Iss. 4, 2004-11 ,pp. : 179-183

Karger

Access to resources Recommend Favorite

Sequential Use of Deferiprone and Desferrioxamine in Primary School Children with Thalassaemia major in Turkey

By  

Acta Haematologica, Vol. 102, Iss. 1, 1999-09 ,pp. : 17-21

Karger

Access to resources Recommend Favorite

Safety and Effectiveness of 100 mg/kg/day Deferiprone in Patients with Thalassemia Major: A Two-Year Study

By  

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 146-149

Karger

Access to resources Recommend Favorite

Deferiprone Chelation Therapy for Thalassemia Major

By  

Acta Haematologica, Vol. 122, Iss. 2-3, 2009-11 ,pp. : 155-164

Karger

Access to resources Recommend Favorite